Sponsored Ad | Artotel Wonderlust: Waktu Indonesia Semarak - Leaderboard

Japan's Astellas Pharma maintains full-year profit forecast amid overseas M&A

Japan's Astellas Pharma maintains full-year profit forecast amid overseas M&A

31 January, 2020

Astellas Pharma Inc

Printed by Unregistered user on Wed, 13 Aug 2025 16:38:54 GMT

Bring stories like this into your inbox every day.

Sign up for our newsletter - The Daily Brief

Subscribe to Newsletter

You may also like

China-based drug developer Adagene raises $69m led by General Atlantic

Chinese contract drugmaker Pharmaron raises $589m in HK listing

Read more from Rest of Asia

Japan’s Nikkei scales record high, SoftBank leads tech surge

Abu Dhabi’s Zero Two joins Warburg Pincus as co-owner of Evolution Data Centres